Bio Rad logo

Bio Rad

Stock
Stock
ISIN: US0905722072
Ticker: BIO
US0905722072
BIO

Price

Price

Frequently asked questions

What is Bio Rad's market capitalization?

The market capitalization of Bio Rad is $9.16B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Bio Rad?

Bio Rad's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$27.32. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Bio Rad's stock?

Currently, 5 analysts cover Bio Rad's stock, with a consensus target price of $352.80. Analyst ratings provide insights into the stock's expected performance.

What is Bio Rad's revenue over the trailing twelve months?

Over the trailing twelve months, Bio Rad reported a revenue of $2.58B.

What is the EBITDA for Bio Rad?

Bio Rad's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $492.89M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Bio Rad?

Bio Rad has a free cash flow of $223.75M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Bio Rad's stock?

The 5-year beta for Bio Rad is 0.90. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Bio Rad have, and what sector and industry does it belong to?

Bio Rad employs approximately 8,030 people. It operates in the Health Care sector, specifically within the Scientific & Technical Instr. industry.

What is the free float of Bio Rad's shares?

The free float of Bio Rad is 19.45M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$9.16B

5Y beta

 
0.90

EPS (TTM)

 
-$27.32

Free Float

 
19.45M

Revenue (TTM)

 
$2.58B

EBITDA (TTM)

 
$492.89M

Free Cashflow (TTM)

 
$223.75M

Pricing

1D span
$325.47$330.05
52W span
$262.12$387.99

Analyst Ratings

The price target is $352.80 and the stock is covered by 5 analysts.

Buy

1

Hold

4

Sell

0

Information

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

8,030

Scientific & Technical Instr.

Health Care

Identifier

ISIN

US0905722072

Primary Ticker

BIO

Knockouts

Join the conversation